Recruiting PHASE4 Healthy

New treatment option for Healthy

Official title Observing Metabolism of EPA With Consideration of Genetics And Sex

ClinicalTrials.gov ID: NCT06975241

What this study is testing

What it's testing
The goal of this clinical study is to learn how fast EPA is converted to other molecules, including DHA, with consideration of biological sex and genetics in healthy humans. The main questions it aims to answer are: How fast is EPA converted to DHA in blood, and is the conversion rate affected by sex and a specific genotype we previously identified?
  • Phase 4: studies an already-approved treatment

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 35. Healthy volunteers may be eligible.

You may be able to join if

  • BMI between 18.5- 30 kg/m2
  • healthy

You likely can't join if

  • Consumption of fish/seafood or EPA/DHA-enriched foods currently or within the previous 6 months
  • Consumption of any supplements containing ALA/EPA/DHA currently or within the previous 6 months
  • Allergies to any component of the study supplement (fish, gelatin etc.)
  • BMI \ 30 kg/m²
  • Women who are pregnant, breastfeeding or planning on becoming pregnant
  • Diagnosis with chronic or communicable diseases
See the full eligibility criteria
Who can join
  • BMI between 18.5- 30 kg/m2
  • healthy
What rules you out
  • Consumption of fish/seafood or EPA/DHA-enriched foods currently or within the previous 6 months
  • Consumption of any supplements containing ALA/EPA/DHA currently or within the previous 6 months
  • Allergies to any component of the study supplement (fish, gelatin etc.)
  • BMI \ 30 kg/m²
  • Women who are pregnant, breastfeeding or planning on becoming pregnant
  • Diagnosis with chronic or communicable diseases
  • Prescription of chronic pharmacological medications (except for oral contraceptives)
  • High blood pressure (systolic or diastolic blood pressure above 130 or 80mmHg, respectively)
  • Hypertriglyceridemia (serum \> or = 1.69 mmol/l)
  • Hypercholesterolemia (serum LDL-C \> or =5 mmol/l)
  • Anticipated changes in lifestyle within the next 4 months
  • Smoking
  • Heavy alcohol use (\>3 drinks/day)
  • Major surgery in the last six months

The study team makes the final eligibility decision.

Where it's taking place

  • Toronto, Ontario, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.